The global avian influenza vaccines market size valued USD 129.6 million in 2020 and expected to reach USD 183.2 million by 2027, at a CAGR of 4.8% during the forecast period 2021-2027. The paradigm shift towards white meat is expected to fuel the demand for poultry industry. Considering the positive socio-economic aspects, the domestic poultry industry, predominantly consisting of broiler meat and table eggs, is anticipated to grow at a considerable pace in the medium to long-term. The escalated demand for eggs and chicken can be attributed to the increase in the income levels, coupled with the purchasing power of parity. Some of the key factors favouring the market growth include growing prevalence of diseases, high demand for poultry for consumption, increasing number of outbreaks and ongoing research for the development of effective vaccines for disease prevention. However, lack of awareness about the disease among people maintaining poultry is the major factor inhibiting the market growth. This report studies global avian influenza vaccines market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global avian influenza vaccines market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global avian influenza vaccines market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).